News & Events

BEAM Alliance
Members
Events

Latest news from BEAM Alliance

6 February 2025 - BEAM ALLIANCE

Join us at the AMR conference!

The AMR Conference is 2 days of updates on the latest developments in the fight against microbial resistance, from a…

26 September 2024 - BEAM ALLIANCE

New York, From inside the UN buildings – Remko van Leeuwen

Just a few hours ago the General Assembly of the UN has adopted a new declaration on fighting AMR. Regardless…

17 September 2024 - BEAM ALLIANCE

General Pharmaceutical Legislation Revision: Taking Stock of the EU Parliament Position and Moving Forward

The BEAM Alliance would like to reiterate its call for optimal PULL incentives designed to fit innovators’ needs based on…

24 October 2023 - BEAM ALLIANCE

BEAM Alliance shares its views on the ongoing revision of the General Pharmaceutical Legislation

We call on policymakers to stop postponing decisions and either propose a clear incentive package now or reintroduce the TEE…

5 September 2023 - BEAM ALLIANCE

BEAM Alliance is Launching a new Task Force to address Issues from the AMR Diagnostics Segment

The new Task Force is gathering innovative SMEs operating in the AMR field and external experts.

16 June 2023 - BEAM ALLIANCE

Possible roles of DG HERA

The report represents an important step towards the implementation of a tangible solution to fix the AMR market. Although the…

No results

1 / 7

Latest news of BEAM Members

11 February 2025 - BioVersys

BioVersys successfully advances BV500 NTM program with continued support from CF AMR syndicate

The company’s BV500 NTM program is derived from its proprietary Ansamycin Chemistry platform from which the research team has identified…

5 February 2025 - Basilea Pharmaceutica International

Strong launch for Cresemba in Japan triggers first sales milestone payment from AKP to Basilea

The strong sales ramp-up in the early stage of its life cycle in Japan underscores that Cresemba is meeting critical…

28 January 2025 - Basilea Pharmaceutica International

Strong sales growth for Cresemba and Zevtera trigger further milestone payments to Basilea

The sales in 2024 of the antifungal Cresemba® (isavuconazole) and the antibiotic Zevtera® (ceftobiprole) exceeded thresholds triggering sales milestone payments…

8 January 2025 - Basilea Pharmaceutica International

Basilea provides portfolio update and outlook

Throughout 2025, we aim to continue both progressing our current R&D assets and expanding our portfolio through targeted in-licensing and…

23 December 2024 - Basilea Pharmaceutica International

Basilea is awarded additional CARB-X funding to develop new drug candidate from a novel class of antibiotics

LptA inhibitors have the potential to address an unmet medical need in the hospital-based treatment of severe infections, caused by…

16 December 2024 - Basilea Pharmaceutica International

Basilea announces agreement with Innoviva Specialty Therapeutics for the commercialization of antibiotic Zevtera® (ceftobiprole) in the United States

Ceftobiprole, the active moiety of the prodrug ceftobiprole medocaril, is an advanced generation cephalosporin antibiotic for intravenous administration, with rapid…

No results

1 / 62

Events

17 March 2025

BIO-Europe Spring® 2025 – 19th Annual International Partnering Conference

BIO-Europe Spring will bring together over 3,700 leading executives from around the world. Specifically, we will host more than 20,000…

27 February 2025

REVIVE Webinar: In vitro and in vivo correlations for prediction of human pharmacokinetics and dose of antimicrobials

This live webinar including an interactive Q&A session will be broadcast on 27 February 2025 at 17:00-18:30 CET.

25 February 2025

9th AMR Conference

Save the date! The 9th AMR Conference will be organized as a face-to-face event on 25-26 February 2025, in Basel.…

23 January 2025

REVIVE Webinar: Implementation research for the appropriate use of, and access to, antimicrobials

This live webinar including an interactive Q&A session will be broadcast on 23 January 2025 at 17:00-18:30 CET.

3 December 2024

REVIVE Webinar: Implementation research for the appropriate use of, and access to, antimicrobials

This webinar will explore how implementation research has successfully led to the updating of guidelines for other drugs and discuss…

4 November 2024

BIO-Europe ® 2024 – 30th Annual International Partnering Conference

Over the last 30 years, BIO-Europe, has become Europe’s flagship partnering event. Its international reach makes it a one-of-a-kind offering,…

No results

1 / 27

Legal notice | Photo credits

Connect with us

contact@beam-alliance.eu
29 Avenue Tony Garnier 69007 Lyon - France